Efficacy of Adalimumab in Sarcoidosis

Journal of Translational Medicine - United Kingdom
doi 10.1186/1479-5876-8-s1-p10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy of Adalimumab in a Patient With Juvenile Idiopathic Arthritis and Uveitis

Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child HealthPediatricsPerinatology
2012English

Efficacy of Adalimumab in Patients With Crohn's Disease and Failure to Infliximab Therapy: A Clinical Series

Revista Espanola de Enfermedades Digestivas
MedicineGastroenterology
2011English

OP0021 Efficacy and Safety Results of a Phase Iii Study Comparing Fkb327, an Adalimumab Biosimilar, With the Adalimumab Reference Product in Patients With Active Rheumatoid Arthritis

2017English

437 Efficacy and Safety of Tumor Necrosis Factor Inhibitors in Cutaneous Sarcoidosis: A Systematic Review

Journal of Investigative Dermatology
BiochemistryDermatologyCell BiologyMolecular Biology
2018English

Meta‐analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Longterm Safety and Efficacy of Adalimumab and Infliximab for Uveitis Associated With Juvenile Idiopathic Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2018English

AB0954 a Randomised, Double-Blind Trial Comparing the Efficacy, Safety and Immunogenicity of Msb11022, a Proposed Biosimilar of Adalimumab, Versus Adalimumab Originator in Patients With Moderate-To-Severe Plaque Psoriasis

2018English

FRI0618 Adalimumab in Non-Infectious Uveitis – Efficacy Across Different Etiologies in the Visual I and Visual Ii Trials

2017English

Efficacy and Safety of Infliximab Versus Adalimumab in the Therapy of Fistulizing Crohn Disease: A Systematic Review and Indirect Comparison

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy